DK1488240T3 - Påvisning af specifikke nitrerede markører - Google Patents

Påvisning af specifikke nitrerede markører

Info

Publication number
DK1488240T3
DK1488240T3 DK03711987.2T DK03711987T DK1488240T3 DK 1488240 T3 DK1488240 T3 DK 1488240T3 DK 03711987 T DK03711987 T DK 03711987T DK 1488240 T3 DK1488240 T3 DK 1488240T3
Authority
DK
Denmark
Prior art keywords
nitrated
detection
markers
oxidative
diseases
Prior art date
Application number
DK03711987.2T
Other languages
English (en)
Inventor
Jean-Yves Reginster
Michelle Deberg
Yves Henrotin
Stephan Christgau
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege filed Critical Univ Liege
Application granted granted Critical
Publication of DK1488240T3 publication Critical patent/DK1488240T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173076—Nitrite or nitrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
DK03711987.2T 2002-03-13 2003-03-12 Påvisning af specifikke nitrerede markører DK1488240T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36392502P 2002-03-13 2002-03-13
DKPA200200381 2002-03-13
PCT/EP2003/002559 WO2003076946A2 (en) 2002-03-13 2003-03-12 Detection of specific nitrated protein markers

Publications (1)

Publication Number Publication Date
DK1488240T3 true DK1488240T3 (da) 2010-03-01

Family

ID=27806430

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03711987.2T DK1488240T3 (da) 2002-03-13 2003-03-12 Påvisning af specifikke nitrerede markører

Country Status (8)

Country Link
US (4) US7393649B2 (da)
EP (1) EP1488240B1 (da)
AT (1) ATE445842T1 (da)
AU (1) AU2003218743A1 (da)
DE (1) DE60329663D1 (da)
DK (1) DK1488240T3 (da)
ES (1) ES2335095T3 (da)
WO (1) WO2003076946A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003218743A1 (en) * 2002-03-13 2003-09-22 Universite De Liege Detection of specific nitrated protein markers
US20050244905A1 (en) * 2004-04-29 2005-11-03 Harry Ischiropoulos Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation
US8852879B2 (en) * 2004-04-29 2014-10-07 The Children's Hospital Of Philadelphia Materials and methods for the detection of nitrated fibrinogen
FR2908413B1 (fr) * 2006-11-15 2009-03-06 Synarc Soc Par Actions Simplif Marqueur specifique d'une degradation oxydative de tissus contenant du collagene de type iii,moyens et methodes,kits de diagnostic de suivi ou de pronostic des pathologies ciblees par ce marqueur.
FR2926369A1 (fr) * 2008-01-10 2009-07-17 Univ Joseph Fourier Utilisation d'une proteine ou d'une sequence peptidique nitree pour la mise en oeuvre d'une methode de diagnostic
US10175250B2 (en) * 2012-06-11 2019-01-08 Gabriela Venturini Da Silva Nitrated cardiac troponin I as a biomarker of cardiac ischemia
AU2013251276A1 (en) 2013-07-18 2015-02-05 Northern Sydney Local Health District Biomarkers of oxidative stress
JP2021155362A (ja) * 2020-03-27 2021-10-07 株式会社ナリス化粧品 ペルオキシナイトライト活性阻害方法および、ペルオキシナイトライト活性阻害剤のスクリーニング方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702909A (en) * 1987-11-06 1997-12-30 Washington Research Foundation Methods of detecting collagen type II degradation in vivo
US6132976A (en) * 1992-12-04 2000-10-17 Shriners Hospitals For Children Immunoassays for the measurement of collagen denaturation and cleavage in cartilage
WO1996004311A1 (en) 1994-08-03 1996-02-15 University Of Alabama At Birmingham Research Foundation Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease
FR2757864B1 (fr) * 1996-12-30 1999-03-19 Centre Nat Rech Scient Anticorps reconnaissant specifiquement une proteine nitrosylee, leur procede de preparation, leur utilisation therapeutique et diagnostique
FR2762602B1 (fr) * 1997-04-28 1999-06-04 Inst Nat Sante Rech Med Moyens pour la detection precoce de pathologies auto-immunes inflammatoires
GB9928052D0 (en) 1999-11-26 2000-01-26 Osteometer Biotech As Assay of isomerised and/or optically inverted proteins and protein fragments
US20030165983A1 (en) * 2000-05-02 2003-09-04 Gibson Bradford W. Proteomic determination of protein nitrotyrosine modifications using mass spectrometry
US6812212B2 (en) * 2000-07-28 2004-11-02 Hyesook Kim Assessment of oxidant stress in vitro and in vivo
AU2003218743A1 (en) * 2002-03-13 2003-09-22 Universite De Liege Detection of specific nitrated protein markers

Also Published As

Publication number Publication date
WO2003076946A3 (en) 2004-03-25
AU2003218743A8 (en) 2003-09-22
US20090203040A1 (en) 2009-08-13
US8329874B2 (en) 2012-12-11
EP1488240B1 (en) 2009-10-14
ES2335095T3 (es) 2010-03-22
US20110223684A1 (en) 2011-09-15
EP1488240A2 (en) 2004-12-22
WO2003076946A2 (en) 2003-09-18
DE60329663D1 (de) 2009-11-26
US20120010389A1 (en) 2012-01-12
AU2003218743A1 (en) 2003-09-22
US7393649B2 (en) 2008-07-01
ATE445842T1 (de) 2009-10-15
US7915001B2 (en) 2011-03-29
US20050176081A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
BR0308585A (pt) Anticorpos anti-alfavbeta6
CY1108937T1 (el) Χρηση της κινασης πρωτεϊνης ν-β
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
ATE455127T1 (de) Humane anti-humane cd3-bindungsmoleküle
BR0315157A (pt) Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
ATE391174T1 (de) Modifizierter tpo-agonisten antikörper
IS2739B (is) Nógó@@@hlutleysandi@ónæmisglóbúlín@fyrir@meðhöndlun@á@taugasjúkdómum
DE602004019812D1 (de) Marker für neuromyelitis optica
HRP20070196T3 (hr) Postupak za pročišćavanje il-18 vezivnog proteina
EE200700052A (et) Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
BRPI0314814B8 (pt) anticorpo compreendendo uma variante de fc
TW200510459A (en) RG1 antibodies and uses thereof
UY26815A1 (es) Métodos para tratar enfermedades reumáticas al usar una molécula ctla4 soluble
CY1110759T1 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
PT1557462E (pt) Células de indução da aceitação de um transplante de origem monocítica e a sua preparação e utilização
DK1895017T3 (da) Anvendelse af A33-antigener og JAM-IT
EA200601217A1 (ru) Новые конденсированные пирролокарбазолы
NO20063193L (no) Fusjonerte pyrrolokarbazoler og fremgangsmater for fremstilling derav
DK1488240T3 (da) Påvisning af specifikke nitrerede markører
PT840620E (pt) Antagonistas de il-8 para o tratamento de asma
WO2005019475A3 (en) Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.